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Abstract
A volunteer effort by Artificial Intelligence (AI) researchers has shown it can deliver significant research outcomes rapidly to 
help tackle COVID-19. Within two months, CLAIRE’s self-organising volunteers delivered the World’s first comprehensive 
curated repository of COVID-19-related datasets useful for drug-repurposing, drafted review papers on the role CT/X-ray 
scan analysis and robotics could play, and progressed research in other areas. Given the pace required and nature of voluntary 
efforts, the teams faced a number of challenges. These offer insights in how better to prepare for future volunteer scientific 
efforts and large scale, data-dependent AI collaborations in general. We offer seven recommendations on how to best lever-
age such efforts and collaborations in the context of managing future crises.
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Introduction
Inspired by successful early use of AI by China, Taiwan, 
Singapore and South Korea to support the management of 
the COVID-19 pandemic, on 20 March 2020 CLAIRE, the 
Confederation of Laboratories for AI Research in Europe 
(CLAIRE) launched a volunteer effort to help tackle the 
pandemic. As the World’s largest, non-profit network of 
AI researchers, CLAIRE was quickly able to recruit 150 
volunteer AI researchers. This report describes the major 
activities and achievements of these volunteers, and shares 
experiences, lessons learnt and recommendations.
The starting point for CLAIRE’s COVID-19 initiative 
was the insight that the AI community has much to offer in 
support of efforts to handle the pandemic, its societal and 
economic consequences, and many AI researchers and prac-
titioners stood ready to help public institutions in the front 
line of the crisis (Luengo-Oroz et al. 2020). Our conviction 
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was that AI could be successfully used across a broad spec-
trum of areas directly related to managing the COVID-19 
crisis, such as:
– Analysis of existing drugs to test their efficacy against 
COVID-19
– Analysis of data from patients in intensive care, to sup-
port prioritisation in triage and therapy
– Analysis of epidemiologic and mobility data, with the 
goal of better modelling and predicting the spread of the 
virus, and of facilitating the assessment of impact of con-
tainment actions
– Use of advanced 3D printing approaches, with the goal 
of alleviating the scarcity of equipment for protection and 
intensive therapy
– Use of automated scheduling and resource management 
approaches, with the goal of efficiently managing scarce 
resources in the medical sector (ICU beds, ventilators, 
specialists) and other key elements of public infrastruc-
ture (personnel, warehouses).
These and many other examples suggest that AI tech-
niques can play a key role in assisting human experts with 
managing the pandemic and its economic aftermath. We note 
that, as evident even from the small set of examples given 
above, it is clear that a broad spectrum of AI techniques and 
approaches can be brought to bear; for this reason CLAIRE, 
whose research network spans all areas of AI, across all of 
Europe, saw itself as particularly well-positioned to mobilise 
bottom-up support for the use of AI techniques and exper-
tise in fighting the pandemic and in managing its impact on 
societies across Europe and the world.
Setup phase
Directly after CLAIRE’s COVID-19 initiative was launched 
in late March 2020, a task force was put into place to coordi-
nate the effort and the volunteer experts supporting it.
This task force collected information on the various initi-
atives on leveraging AI techniques in the context of COVID-
19 and supported the development of new projects, connect-
ing the European network of AI experts together with health 
institutions and governments. By the end of March, the task 
force had enrolled 150 volunteers, covering the full spectrum 
of AI methods, tools and technologies. Volunteers indicated 
their willingness to work on one or more of 11 research top-
ics. Of these, a significant number of volunteers and topic 
team leaders were found for 7 topics:
• Epidemiological data analysis—10 volunteers
• Mobility and monitoring data analysis—36 volunteers
• Bioinformatics (protein and molecular data analysis)—25 
volunteers
• Image analysis (CT scans, X-ray)—47 volunteers
• Social dynamics and networks monitoring—8 volunteers
• Robotics—5 volunteers
• Scheduling and resource management—30 volunteers
AI & COVID‑19 resource database
An initial challenge was to ensure volunteers were aware 
of other initiatives already underway globally. By crowd-
sourcing volunteers’ efforts, a catalogue of AI & COVID-
19 related resources was assembled. Although not designed 
to be exhaustive, this catalogue now lists 129 resources, 
covering:
• Funding opportunities (21 calls still open at time of draft-
ing)
• Datasets (30 resources)
• Hackathons, challenges and webinars (7 listed)
• Other initiatives (71 listed)
To enlarge the list of initiatives and provide additional 
information to our volunteers we linked our database to the 
following catalogues of funding and initiatives:
• GovLab repository
• COVID-19 research funding monitor
• Coronavirus Funding Opportunities
• NIH Open-Access Data and Computational Resources to 
Address COVID-19
Overview of research activities
The 7 groups of volunteers, led by the topic coordinators 
and with the support of the task force team, are working on 
several outcomes summarised below.
Epidemiological modeling and decision support
Topic coordinator: Ann Nowé, Vrije Universiteit Brussel, 
Belgium.
No. of volunteers: 10.
This research group works on different types of models 
for epidemics (Pernice et al. 2020; Report 9: Impact of non-
pharmaceutical interventions (NPIs) Response Team xxxx; 
Data Science Institute and UHasselt xxxx), ranging from 
high level compartment models to agent based models, 
and how they can be used to study the dynamical aspects 
to improve complex decision taking on the effectiveness of 
prevention strategies. On the one hand, this involves model 
fitting and optimisation, on the other hand, learning and 
optimisation of prevention strategies, using epidemiological 
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models as simulation environments (Libin and Guiding . 
xxxx).
Work is underway to identify collaboration mechanisms 
and structures, considering the support AI can offer in deci-
sion-making. This recognises the multi-criteria nature of the 
problem, balancing the needs of different stakeholders all of 
whom should be involved.
Mobility and monitoring data analysis
Topic coordinator: Jose Sousa, Faculty of Medicine, Health 
and Life Sciences, Queen’s University Belfast, Northern 
Ireland.
No. of volunteers: 36.
This work sets out to understand the symptoms progres-
sion through self-reported data and its integration with 
mobility to forecast healthcare decision making. The goal is 
the development of an AI multilayer learning approach capa-
ble of creating evidence based knowledge, using complex 
networks for self-supervised learning (LeCun et al. 2015), 
spatial temporal analysis and deep learning.
Work is underway to understand the data collected under 
the several self-reporting systems (Sun et al. 2020) and test 
how useful the self-reported data is to forecast events (Real-
time tracking of self-reported symptoms to predict potential 
COVID-19 2020). The initial models will be produced using 
different methodologies and compared with the officially 
reported statistics.
Bioinformatics (protein and molecular data analysis)
Topic coordinator: Davide Bacciu, Computational Intel-
ligence and Machine Learning Group, Universita’ di Pisa, 
Italy.
No. of volunteers: 35.
Work on this topic aims to (1) support the community in 
characterising the disease from its related structural informa-
tion, including prediction of viral protein folding; (2) study 
the interactions between the virus and human hosts, includ-
ing analysing protein–protein interaction data; (3) design 
and validate methodologies for filtering, retrieval, and gen-
eration of targeted drugs leveraging molecular and well as 
proteomic information; (4) deliver predictive insights onto 
the genetic features of the virus.
As a first contribution to the community, the workgroup 
has created a curated collection of COVID-19-related data-
sets useful for drug-repurposing tasks, integrating data from 
multiple studies (Cheng et al. 2019; Ashburner et al. 2000; 
Janet Piñero et al. 2019; Rose Oughtred et al. 2019) and 
releasing it as a network comprising protein interactions 
(Cheng et al. 2019), viral-host interactions (Rose Oughtred 
et al. 2019), genomic information (Ashburner et al. 2000) 
and drug interactions (Cheng et al. 2019). This resource has 
already been released to the community. The group will use 
the resource to provide a methodology for fast retrieval of 
drugs whose action can be correlated to target proteins, by 
leveraging deep learning for graphs (Bacciu et al. 2020).
Image analysis (CT scans)
Topic coordinator: Marco Aldinucci, Computer Science 
Dept, University of Torino, Italy.
No. of volunteers: 48.
Research in this area aims to (1) distil the current state 
of the art of methodologies and data sets for AI-assisted 
diagnosis of COVID-19 by way of imaging (TC Scan, X-ray, 
etc.), with the goal of making diagnosis faster, cheaper and 
more manageable in the hospital processes (e.g. using low-
resolution images); and (2) to contribute to the improvement 
of multidisciplinary knowledge by cross-breeding knowl-
edge in computer science and radiology aiming at creating 
better, more informative reference datasets, together with 
data-gathering strategies, beyond the current outbreak (Tart-
aglione et al. 2004; Shi et al. 2020).
The team is developing a review paper and contributes 
to already active projects, including EU H2020 DeepHealth 
and EU ERDF HPC4AI. Two further projects are motivated 
by the strongly perceived need to distil science from the 
hype COVID-19 induced in different aspects of everyday 
life, including scientific works (Deephealth project: EU ICT-
2018; EU ICT-2018).
The first addresses a reproducibility and benchmarking 
task: the main publically available deep neural networks 
and datasets will be collected and cross-validated to com-
pare them across a common baseline. This task will need a 
substantial human and compute effort. For this, the group 
is finalising an agreement with the Italian National Super-
computing Center CINECA that will actively support the 
group activity, which will require both training and inference 
of the cartesian product of networks, datasets and network 
parameters. A non-trivial but enabling aspect of the work 
will be designing and experimenting tools making it pos-
sible to bring AI workload to supercomputers and make AI 
experts efficiently use large scale platforms (Aldinucci et al. 
2018; Colonnelli et al. 2002).
The second seeks to consolidate AI performance met-
rics for both datasets and networks, which will be needed to 
assess both quality and compute efficiency aspects.
Social dynamics and networks monitoring
Topic coordinator: Manlio De Domenico, Head of Com-
plex Multilayer Networks Lab—Fondazione Bruno Kessler 
(FBK), Italy.
No. of volunteers: 8
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This work uses AI models to analyse social media data 
together with social, behavioral and economic data for two 
main purposes: (1) monitor social dynamics to analyse the 
COVID-19 “infodemic” – “an over-abundance of informa-
tion – some accurate and some not – that makes it hard for 
people to find trustworthy sources and reliable guidance 
when they need it” (WHO - Novel Coronavirus(2019)–with 
the goal of identifying, monitoring and analysing the over-
load of unreliable information; of collaborating with data 
providers to obtain free access to relevant data; and of cre-
ating an interdisciplinary hub of experts to fight the “info-
demic”; and (2) develop early-warning signals to support 
policy, informed by spatio-temporal analysis of emotions 
and sentiments; quantifying and modelling the socio-behav-
ioural response. Social media are playing a crucial role for 
spreading information, both reliable and unreliable, during 
the COVID-19 pandemic. Efforts are devoted to unravel 
the role played by both humans and software-assisted (i.e., 
social bots) in disseminating false or inflammatory content 
for social manipulation, a phenomenon recently discovered 
during political events (Stella et al. 2018), with the ultimate 
goal of attracting or driving collective attention (Domen-
ico and Altmann 2020) towards a specific information. 
Products of the individual team members, such as the info-
demic observatory model (Gallotti et al. 2004) developed by 
the topic coordinator within the Complex Multilayer Net-
works Lab at FBK, allow to monitor the current infodemic 
globally, in each country, or at sub-regional resolution in 
real time. Information, complemented with the analysis of 
cognitive content, based on natural language processing and 
computational psycholinguistics, might help to shed light on 
mass psychology and socio-behavioral response to the pan-
demic. Results can be used to support policy and decision 
makers with adequate and zone-specific actions.
Such tools can be disseminated and further developed 
with the support of the entire research team.
Robotics
Topic coordinator: Alessandro Saffiotti, AASS Cognitive 
Robotic Systems Lab, School of Science and Technology, 
Orebro University, Sweden.
No. of volunteers: 5
Work in this area investigates possible uses of robotic 
systems and robotic technologies in response to the cur-
rent COVID-19 emergency and to its aftermaths, as well as 
strategies to improve technological preparedness to possible 
future crises Specifically, this team has studied: the use of 
mobile robots for disinfection of environments; specialized 
laboratory robots for biological tests and drug develop-
ment; telepresence robots for social and medical assistance; 
manufacturing robots for flexible production. These uses of 
robotic technologies are in line with a recent editorial in 
Science Robotics (Yang 2020).
The group maintains a catalogue of robotic offers and 
demands relevant to the COVID-19 emergency, and it is 
liasing active research laboratories across Europe. We have 
found that the liaison aspect is especially important during 
a crisis, when access to laboratory resources and material 
may be seriously limited. It is also supporting euRobotics 
(the association of European robotic stakeholders) in writing 
a white paper on the potential usage of robotic technology in 
the COVID-19 emergency.
Scheduling and resource management
Topic coordinator: Marco Maratea, Dipartimento di Infor-
matica, Bioingegneria, Robotica e Ingegneria dei Sistemi. 
University Genova, Italy.
No. of volunteers: 30.
The group working on this topic has focused on auto-
mated planning and scheduling, and resource management in 
healthcare systems leveraging AI (deductive) methodologies 
and tools. An initial assessment of relevant resources has 
been completed, and a review of relevant publications, data 
and projects is underway. In addition, collaboration with the 
Galliera hospital in Genova, Italy, is underway to assist with 
workforce scheduling and automated planning of the utilisa-
tion of operating rooms with scarce resources and equipment 
(Alviano et al. 2018; Dodaro and Galatà 2019).
Recommendations for future efforts 
in a crisis
Unfortunately, it is more than likely that our societies will be 
confronted in the not-so-far future with other crises of simi-
lar scale. The results of our efforts thus far demonstrate that 
rapidly assembled volunteer efforts including large teams 
of experts, although complex to initiate and coordinate, 
can make valuable contributions in this context. Important 
initiatives may result from bottom-up efforts, which may 
consolidate in white papers, joint project applications and 
dissemination of annotated datasets. However, preparedness 
for such future events can be improved in a number of ways, 
and there are important lessons to be learned. Here, we out-
line some of our experiences and cautiously formulate some 
recommendations based on these.
Involving domain experts and public authorities 
is difficult in a crisis
Many domain experts in public and medical authorities were 
already preoccupied with tackling the pandemic, limiting 
their scope to assist volunteer teams. As a result, teams had 
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to develop their own analysis of the problems to tackle, seek-
ing to engage with experts later in the development process 
as the crisis began to be controlled. The teams who most 
rapidly developed research outputs were those where the 
topics being worked on were close to their existing expertise.
Recommendation 1 Effectively interfacing with domain 
experts and public authorities in a crisis situation is chal-
lenging, but this should not discourage qualified volunteers.
Recommendation 2 The contribution that voluntary expert 
teams can make should be taken into account in planning 
for future crises.
See also Recommendation 6 below.
The need for open licenses and standards for data
The ethical implications of processing medical and other 
sensitive data, and the strategic and policy impacts of 
research during a crisis pose major challenges. While 
researchers were fully committed to respecting European 
citizens’ privacy, in accordance with European values, fun-
damental rights and regulations such as GDPR, the weak 
standardisation of the data collected on COVID-19 and 
embryonic state of open data access in the medical and epi-
demiological field made it difficult to compile bigger data 
sets needed for the data-driven approaches. Thus ethical, 
data management and standardisation efforts should be 
carefully considered from the outset of future volunteering 
efforts.
Open licenses designed by Creative Commons have been 
used for several of the products from this effort to encour-
age reuse. CLAIRE has more broadly analysed the Creative 
Commons Open COVID Licence, and welcomes this open 
approach to sharing research products. Accelerating the 
development of open licenses and standards for medical data 
and models, such as epidemiological models, and applying 
them consistently would reduce these challenges in future.
Recommendation 3 Address and coordinate ethical issues, 
standardisation and data management at the beginning of the 
research effort. Consider using open licences to support and 
accelerate data availability.
The need for large open datasets 
and infrastructures
Many AI techniques, notably from the area of machine 
learning, depend on access to large-scale data. Work with 
platforms like Twitter and Facebook, and with mobile tel-
ecommunication service providers, should become more 
routine in the future to help speed up the large-scale analyses 
required to inform policy based on quantitative measures of 
human behavioural responses to the pandemic. This also 
demonstrates the need for a European data space, such as 
that proposed in the European Data Strategy and the Euro-
pean Open Science Cloud, which should include such data-
sets. Of course, it is very important to not only ensure the 
quality of such data sets, but also to protect the rights of 
citizens, in particular their privacy.
Recommendation 4 Support the development of a European 
data space and an open data approach to medical and sensi-
tive data for scientific purposes, while protecting individuals 
anonymity, dignity and human rights.
The role of large scale research infrastructures
The ability of large-scale research and development infra-
structures, such as the Robert Koch and Francis Crick Insti-
tutes (or, indeed, Apple and Google), to redeploy expertise 
to work effectively on the pandemic is notable. They have 
offered public authorities single points of contact for key 
expertise and helped rally efforts of related communities.
Many scientists in AI have shown they are eager to dedi-
cate significant time and effort to voluntary activities which 
might not be necessarily sustainable in a short-time horizon 
or according to more conventional funding channels. The 
CLAIRE initiative purposefully decided to build on this to 
go beyond a sterile communication exercise, to bootstrap 
a number of concrete scientific collaborations on a volun-
tary basis. While this effort has demonstrated that volunteer 
efforts can be effective, this observation supports the case 
for a large-scale investment into an AI hub (or lighthouse 
centre) in Europe, acting as the reference point of European 
nations and institutions for all AI research and development.
Since the largest part of the research community kept on 
using conventional means and strategies to deal with the 
COVID-19 crisis—notably: competitive research funding, 
publication (though accelerated by a largest use of arXiv 
distribution services) and networking—a European centre 
for AI could promote an innovative approach to research 
collaboration, funding and dissemination.
Fast international uptake was only possible thanks to 
existing research networks and network organisations, or 
built upon personal international academic networks or 
ongoing project consortia. Outreach and links to initiatives 
across the EU network were difficult to deploy or to set up, 
given the grass-roots nature of most initiatives.
A European network would establish permanent relations 
with all the relevant AI institutions and initiatives globally.
Recommendation 5 Establish a European hub (or lighthouse 
centre) for AI of very substantial scale.
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Bridging communication between medical and AI 
expertise
The software platforms and hardware with suitable computa-
tional power needed to make use of advanced AI techniques 
(as recommended by AI experts) are lacking in many hospital 
environments, whether for e-Health or other solutions. While 
the function of hospitals is first-and-foremost to deliver medi-
cal care, encouraging the future development collaborations 
between local hospitals and AI researchers and investment into 
infrastructure that enables these collaborations during normal 
times would help reduce these barriers in future crises. The 
approach can be extended to other areas using, for example, 
national risk registers that identify topics of concern to build 
networks with those who have to manage crises.
Recommendation 6 Set up stable collaboration between 
hospitals and AI researchers, and other areas of work where 
future crises can be expected.
Organising large teams remotely
Remotely organising teams of as many as 47 volunteers to 
quickly decide on research priorities and means of deliv-
ering that research presents its own challenges. Preventing 
fragmentation that dilutes effort, documenting research 
plans and the work underway, communicating effectively 
within the group and disseminating results become signifi-
cant overheads that are not easy to resolve using slow, tradi-
tional methods. There is a rich selection of tools available to 
address many of these issues, used especially in the software 
industry, but familiarity with these tools within the scientific 
community varies greatly. This pushes teams towards the 
simplest, lowest-common-denominator, legacy solutions as 
well as towards pre-existing networks and project teams. 
While even simple videoconferencing and document shar-
ing tools have enabled substantial work to be progressed and 
completed, scientific researchers should build their familiar-
ity with complex and feature-rich collaboration tools that 
now exist. This will improve inter-institutional research, 
assisting both building of teams, internal collaboration, and 
dissemination of results.
Recommendation 7 Scientific researchers should become 
fluent with the collaboration tools and techniques routinely 
used, for example, in the software industry.
Conclusions
As the COVID-19 pandemic and its wider ramifications have 
yet to play out, it is far too early to draw any definitive conclu-
sions. But the outcomes of CLAIRE’s COVID-19 initiative 
suggest that bottom-up, expert-driven, non-profit endeavours 
can play an important role. It also offers further evidence sup-
porting the basic premise that AI can and should play a key 
role in handling crises such as this one, both in the health 
and medical aspects of the COVID-19 pandemic, and in the 
societal and economic recovery to come. The highly inter-
disciplinary nature of AI makes it an ideal discipline to cre-
ate bridges with other scientific domains to attack important 
societal problems and crises.
In crises resources are limited, time is of the essence and 
the consequences of action or inaction are severe but difficult 
to predict. We are convinced that AI, with its potential to sup-
port human analysis, planning and decision making has much 
to offer not just in the context of the current pandemic, but also 
for handling future crises. We have shown that many experts 
are willing to work quickly together on novel solutions for the 
benefits of society. Such collaboration depends on quick access 
to large amounts of data and information, computation and, 
most importantly, to each other even when social distancing 
measures severely restrict physical interaction.
We remain aware that when used, developed and deployed 
under the pressure of exceptional circumstances, AI technol-
ogy can be a double-edge sword. It is technologically quite 
easy to put in place systems that might be difficult to dial 
back once the crisis is over, eroding privacy and other fun-
damental rights aided by advanced AI tools and techniques. 
We must not allow this to happen and must develop standards 
and frameworks that permit rapid progress without eroding 
human dignity.
Especially in times of crisis, we need to keep our eyes and 
resources firmly on AI that enhances human intelligence, helps 
us recognise and avoid our biases and limitations, and that is 
designed and used to protect and further our interests as indi-
viduals and societies, managing potential risks and reinforc-
ing our European values and the goal of developing human-
centred AI.
Despite its limited scale, the experience of the CLAIRE 
COVID-19 initiative has not only made concrete progress on 
COVID-19 problems, but offered insights on the potential and 
limitations of a non-conventional, voluntary and bottom up 
approach based on the good will of AI experts, fully aware of 
the societal role of their knowledge and of the importance of 
an open dissemination of science and contributions to open 
scientific data collaborations with all stakeholders of our inno-
vation ecosystem.
Additional information on the CLAIRE COVID-19 initia-
tive can be found in the website https ://covid 19.clair e-ai.org/
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